While Inflation Surges Higher, 7 Warren Buffett Dividend Stocks Are Solid Safe Havens24/7 Wall Street • 05/12/22
Merck sees higher profit, sales for 2022 after strong 1Q driven by science unitMarket Watch • 05/12/22
Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab)Business Wire • 05/10/22
The Bear Market Is Here: 7 Safe ‘Strong Buy' Dividend Blue Chips That Will Survive24/7 Wall Street • 05/09/22
Is Merck Stock A Buy As It Eyes At Least $5 Billion From Its Covid Pill?Investors Business Daily • 05/06/22
Breakout Watch: Large-Cap Leader Merck In Spotlight After Earnings Beat And Big Covid Pill SalesInvestors Business Daily • 05/05/22
Merck to Participate in Bank of America Securities 2022 Healthcare ConferenceBusiness Wire • 05/04/22
Called to Account: Drug companies are making an accounting change after the SEC cracked down on BiogenMarket Watch • 05/03/22
7 Goldman Sachs Conviction List Dividend Stocks That Can Weather a Huge Sell-Off24/7 Wall Street • 04/29/22
European Commission Approves Merck's KEYTRUDA® (pembrolizumab) for Patients With Microsatellite Instability-High (MSI-H) or Deficient Mismatch Repair (dMMR) Tumors in Five Different Types of CancerBusiness Wire • 04/29/22
European Commission Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Bevacizumab, for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS ≥1)Business Wire • 04/29/22